Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Intracranial Aneurysm Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of neurological diseases
3.4.1.2. Technological advancements
3.4.1.3. Increasing preferance for targeted therapy approach
3.4.2. Market restraint analysis
3.4.2.1. Risk of DBS surgery
3.4.2.2. Complex regulatory framework
3.5. Intracranial Aneurysm Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Intracranial Aneurysm Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Surgical Clipping
4.1.2. Endovascular Coiling
4.1.3. Flow Diverters
4.1.4. Others
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Intracranial Aneurysm Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Surgical Clipping
4.5.1.1. Surgical clipping market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Endovascular Coiling
4.5.2.1. Endovascular coiling market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Flow Diverters
4.5.3.1. Flow diverters market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Intracranial Aneurysm Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Clinics
5.1.3. Others
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Intracranial Aneurysm Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Clinics
5.5.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Intracranial Aneurysm Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
6.6. North America
6.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 – 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 – 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 – 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 – 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 – 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 – 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 – 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 – 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 – 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 – 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 – 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 – 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 – 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 – 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 – 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 – 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 – 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 – 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive Scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 – 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 – 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Type benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Stryker
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Type benchmarking
7.3.5.4. Strategic initiatives
7.3.6. MicroPort Scientific Corporation.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Type benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Johnson & Johnson Services, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Type benchmarking
7.3.7.4. Strategic initiatives
7.3.8. MicroVention Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Type benchmarking
7.3.8.4. Strategic initiatives
7.3.9. B. Braun Melsungen AG
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Type benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Integra LifeSciences
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Type benchmarking
7.3.10.4. Strategic initiatives
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global intracranial aneurysm market, by region 2018 - 2030 (USD Million)
Table 4 Global intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 5 Global intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 7 North America intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 8 North America intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 9 U.S. intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 10 U.S. intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 12 Canada intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 13 Europe intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 14 Europe intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 15 Europe intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 16 UK intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 17 UK intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 18 Germany intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 19 Germany intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 20 France intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 21 France intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 22 Italy intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 23 Italy intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 24 Spain intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 25 Spain intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 28 Sweden intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 29 Sweden intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 30 Norway intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 31 Norway intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 32 Asia Pacific intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 34 Asia Pacific intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 35 Japan intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 36 Japan intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 37 China intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 38 China intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 39 India intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 40 India intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 42 Australia intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 43 Thailand intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 44 Thailand intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 45 South Korea intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 46 South Korea intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 47 Latin America intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 48 Latin America intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 49 Latin America intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 50 Brazil intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 51 Brazil intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 52 Mexico intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 53 Mexico intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 54 Argentina intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 55 Argentina intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 56 MEA intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 57 MEA intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 58 MEA intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Africa intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 60 South Africa intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 63 UAE intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 64 UAE intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 65 Kuwait intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 66 Kuwait intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer